Sale!

Human ADA Protein

$895.00

Catalog Number: B2011492 ( 50 µg)
Human ADA Protein is a high quality recombinant human ADA protein His tagged and expressed in E. coli. This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.

Live enquiry about this product via Text/SMS: 1-858-900-3210.

In stock

SKU: B2011492 Categories: ,

Description

Human ADA Protein
Catalog number: B2011492
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 µg
Molecular Weight or Concentration: 0.5 mg/mL
Supplied as: Solution
Applications: molecular tool for various biochemical applications
Storage: -20 °C
Keywords: ADA protein (His tag), ADA1 protein, Adenosine aminohydrolase protein
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Atiqi S, Hooijberg F, Loeff FC, Rispens T, Wolbink GJ. Immunogenicity of TNF-Inhibitors Front Immunol. 2020 Feb 26;11:312.
2: Liu L. Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins Protein Cell. 2018 Jan;9(1):15-32.
3: Garcês S, Demengeot J. The Immunogenicity of Biologic Therapies Curr Probl Dermatol. 2018;53:37-48.
4: Kimura A, Takekoshi A, Yoshikura N, Hayashi Y, Shimohata T. Clinical characteristics of autoimmune GFAP astrocytopathy J Neuroimmunol. 2019 Jul 15;332:91-98.
5: American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019 Diabetes Care. 2019 Jan;42(Suppl 1):S90-S102.
6: Zoghbi J, Xu Y, Grabert R, Theobald V, Richards S. A breakthrough novel method to resolve the drug and target interference problem in immunogenicity assays J Immunol Methods. 2015 Nov;426:62-9.
7: Banfield C, Rudin D, Bhattacharya I, Goteti K, Li G, Hassan-Zahraee M, Brown LS, Hung KE, Pawlak S, Lepsy C. First-in-human, randomized dose-escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF-06480605 in healthy subjects Br J Clin Pharmacol. 2020 Apr;86(4):812-824.
8: De Groot AS, Scott DW. Immunogenicity of protein therapeutics Trends Immunol. 2007 Nov;28(11):482-90.
9: Meunier S, de Bourayne M, Hamze M, Azam A, Correia E, Menier C, Maillère B. Specificity of the T Cell Response to Protein Biopharmaceuticals Front Immunol. 2020 Jul 22;11:1550.
10: Shankar G, Arkin S, Cocea L, Devanarayan V, Kirshner S, Kromminga A, Quarmby V, Richards S, Schneider CK, Subramanyam M, Swanson S, Verthelyi D, Yim S; American Association of Pharmaceutical Scientists. Assessment and reporting of the clinical immunogenicity of therapeutic proteins and peptides-harmonized terminology and tactical recommendations AAPS J. 2014 Jul;16(4):658-73.

Products Related to Human ADA Protein can be found at Proteins

How to Order

1- Order online using our website’s automated shopping cart and checkout system (available 24/7).

2- Order by email: info@moleculardepot.com (we accept electronic PO, available 24/7).

3- Order by Fax: 1-858-437-9884 (available 24/7).

4- Order by phone: 1-858-900-3210 (6 am – 8 pm PST).

5- Order by Text/SMS: 1-858-900-3210 (6 am – 8 pm PST).